Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease
Crossref DOI link: https://doi.org/10.1038/s41598-021-81959-1
Published Online: 2021-02-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kim, Kwang Min
Roh, Ji-Hye
Lee, Sangjin
Yoon, Jeong-Hyun
Text and Data Mining valid from 2021-02-03
Version of Record valid from 2021-02-03
Article History
Received: 27 September 2020
Accepted: 13 January 2021
First Online: 3 February 2021
Competing interests
: The authors declare no competing interests.